知镜 Cognispect · 医学文献与研究工作台

Theratyping for personalized medicine across cystic fibrosis disease models.

Bezzerri V, Gunawardena T, Gonska T, Chan AP, Salih R, Lucca F, Moraes TJ, Freedman SD, Cipolli M.
Communications medicine · 2026-10-25 · PMID 42928365

文献摘要

In the era of CFTR modulators, cystic fibrosis (CF) is being profoundly reshaped for treatment-eligible individuals. Theratyping, an ex vivo strategy assessing individual responses to CFTR modulators, supports precision medicine, particularly for rare variants where conventional trials are limited. In this Review, we discussed advances in CF disease modelling, highlighting strengths, limitations and translational relevance. We also outlined future directions aligned with the Replacement, Reduction, and Refinement (3 R) ethical principles in animal research, including organ-on-a-chip technologies, to improve mechanistic insight and preclinical predictivity. CF research offers therefore a paradigmatic framework for therapeutic innovation in other rare genetic diseases.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。